DEA Releases 2016 Drug Threat Assessment: Fentanyl-related Overdose Deaths Rising At An Alarming Rate
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • DEA Releases 2016 Drug Threat Assessment: Fentanyl-related Overdose Deaths Rising At An Alarming Rate

DEA Releases 2016 Drug Threat Assessment: Fentanyl-related Overdose Deaths Rising At An Alarming Rate

December 06, 2016
|
Share Article
|
Download Press Release
For Immediate Release
Contact: DEA Public Affairs
Phone Number: (202) 307-7977

Powerful synthetic opioid often added to heroin, sold as heroin to unsuspecting users

WASHINGTON - DEA Acting Administrator Chuck Rosenberg today announced results from the 2016 National Drug Threat (NDTA), which details the extent to which illicit drugs are affecting the United States. Most notably, the 2016 NDTA continues to illuminate the nationwide opioid epidemic, which is fueling a growing heroin user population and resulting in a greater amount of overdoses. In 2014, approximately 129 people died every day as a result of drug poisoning and 61% (79) of them are pharmaceutical opioid or heroin related.1

This opioid epidemic has been exacerbated by the national reemergence of fentanyl - a synthetic opioid which is much more potent than heroin. Fentanyl’s strong opioid properties have made it an attractive drug of abuse. Illicit fentanyl, manufactured in foreign countries and then smuggled into the United States, is a rising factor in the current overdose epidemic. It is usually mixed into heroin products or pressed into counterfeit prescription pills, sometimes without the users’ awareness, which often leads to overdose. The rise in overdose deaths also coincides with the arrival of carfentanil, a fentanyl-related compound, in America’s illicit drug markets. Carfentanil is approximately 10,000 times more potent than morphine. The presence of carfentanil in illicit U.S. drug markets is cause for concern, as the relative strength of this drug could lead to an increase in overdoses and overdose-related deaths, even among opioid-tolerant users.

"Sadly, this report reconfirms that opioids such as heroin and fentanyl - and diverted prescription pain pills - are killing people in this country at a horrifying rate," said Acting Administrator Rosenberg "We face a public health crisis of historic proportions. Countering it requires a comprehensive approach that includes law enforcement, education, and treatment." 
The 2016 NDTA also found that Mexican transnational criminal organizations continue to act as the biggest criminal drug threat to the United States and are the primary suppliers of heroin, cocaine, and methamphetamine. These groups are responsible for much of the extreme violence seen in recent years in Mexico, as they have continually battled for control of territory. Within the U.S., violent gangs affiliated with these drug trafficking organizations are a significant threat to the safety and security of our communities. These gangs receive deadly drugs like heroin from regional cartel affiliates and then supply them to American communities for profit, regardless of the human cost.  

Other 2016 NDTA findings:

  • While there is evidence of a slight decline in the abuse levels of controlled prescription drugs, data indicates an increase in the seizure of counterfeit prescription (many of which contain the extremely potent substance fentanyl).

  • Heroin overdose deaths are high across the United States, particularly in the Northeast and Midwest.  Nationally, overdose deaths more than tripled between 2010 and 2014, with the most recent available data reporting 10,574 people in the United States died in 2014 from heroin overdoses.2
  • Deaths in the “synthetic opioids” category rose 79% from 3,097 in 2013 to 5,544 in 2014. While other opioids are included in this category, public health officials maintain that fentanyl is contributing to most of this increase. Fentanyl is sometimes added to heroin batches, or mixed with other adulterants and sold as counterfeit heroin, unknown to the user.3

  • Methamphetamine continues to be readily available throughout the United States, and methamphetamine distribution and use continues to contribute to violent and property crime in the United States.
  • Cocaine availability and use in the United States increased across multiple fronts between 2014 and 2015 and is likely to continue increasing in the near term. Colombia will remain the primary source of supply for cocaine in the United States, and elevated levels of coca cultivation, potential pure cocaine production, and north-bound movement indicate more cocaine is available for traffickers who want to attempt to re-invigorate the U.S. cocaine market.

The National Drug Threat Assessment provides a yearly assessment of the many challenges local communities face related to drug abuse and drug trafficking. Highlights in the report include usage and trafficking trends for drugs such as heroin, prescription drugs, methamphetamine, cocaine, marijuana, and the hundreds of synthetic drugs.
The assessment factors in information from many data sources such as drug seizures, drug purity, laboratory analyses, information on the involvement of organized criminal groups, and survey data provided to DEA by 1,444 state and local law enforcement agencies across the country.


1. Source Center for Disease Control

2. Source Center for Disease Control

3. Source Center for Disease Control

Download Press Release
Attachments
drug_of_abuse.pdf
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

@DEAHQ
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español